English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/171075
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorHsieh, Chia-Chien-
dc.contributor.authorMartínez Villaluenga, Cristina-
dc.contributor.authorLumen, Ben O. de-
dc.contributor.authorHernández-Ledesma, Blanca-
dc.date.accessioned2018-10-16T09:19:02Z-
dc.date.available2018-10-16T09:19:02Z-
dc.date.issued2018-
dc.identifierdoi: 10.1002/jsfa.8719-
dc.identifiere-issn: 1097-0010-
dc.identifierissn: 0022-5142-
dc.identifier.citationJournal of the Science of Food and Agriculture 98(6): 2070-2079 (2018)-
dc.identifier.urihttp://hdl.handle.net/10261/171075-
dc.description.abstractChronic diseases have become the medical challenge of the 21st century because of their high incidence and mortality rates. Modulation of diet and lifestyle habits is considered as the best strategy for the prevention of these disorders. Health promoting benefits beyond their nutritional effects have been described for multiple dietary compounds. Among these compounds, the peptide lunasin is considered as one of the most promising. Naturally present in soybean, lunasin has been extensively studied in the last two decades because of its potential against chronic diseases such as cancer, cardiovascular and immunological disorders. The purpose of this article is to summarise the evidence on the presence of lunasin in soybean and derived foods, and its bioavailability once it is orally ingested. The protective and therapeutic effects of this peptide against cancer, oxidative stress, inflammation, and high cholesterol levels as well as the molecular mechanisms of action involved in these effects are also described in this review.-
dc.description.sponsorshipC.-C. H. acknowledges funding from the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-003-003-MY3). C. M.-V. and B. H.-L. acknowledge funding from the Ministry of Economy and Competitiveness (MINECO, Spain) (grants AGL2013-43247-R and AGL2015-66886-R).-
dc.publisherSociety of Chemical Industry-
dc.publisherJohn Wiley & Sons-
dc.relationMINECO/ICTI2013-2016/AGL2013-43247-R-
dc.relationMINECO/ICTI2013-2016/AGL2015-66886-R-
dc.relation.isversionofPostprint-
dc.rightsopenAccess-
dc.subjectChronic diseases-
dc.subjectCancer-
dc.subjectLunasin-
dc.subjectChemopreventive and therapeutic properties-
dc.subjectBioactive peptide-
dc.titleUpdating the research on the chemopreventive and therapeutic role of the peptide lunasin-
dc.typeartículo-
dc.relation.publisherversionhttps://doi.org/10.1002/jsfa.8719-
dc.date.updated2018-10-16T09:19:03Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066eng-
dc.contributor.funderMinistry of Science and Technology (Taiwan)-
dc.contributor.funderMinisterio de Economía y Competitividad (España)-
dc.relation.csic-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.identifier.pmid28990666-
Appears in Collections:(ICTAN) Artículos
(CIAL) Artículos
Files in This Item:
File Description SizeFormat 
updatilunasi.pdf348,3 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.